We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+16.49%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$592M
AUM Growth
+$136M
Cap. Flow
+$94.5M
Cap. Flow %
15.97%
Top 10 Hldgs %
41.77%
Holding
162
New
61
Increased
29
Reduced
25
Closed
41

Top Buys

Rank Stock Value
1
STKL
SunOpta
STKL
+$10.2M
2
PCOR icon
Procore
PCOR
+$9.18M
3
UTHR icon
United Therapeutics
UTHR
+$8.86M
4
AMZN icon
Amazon
AMZN
+$6.97M
5
S icon
SentinelOne
S
+$6.81M

Sector Composition

Rank Sector Weight
1 Technology 29.62%
2 Industrials 12.69%
3 Healthcare 8.18%
4 Consumer Staples 5.9%
5 Materials 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$88.7M 14.98%
+200,000
New +$83.9M
STKL
2
DELISTED
SunOpta
STKL
$29M 4.91%
4,342,000
+1,357,000
+45% +$10.2M
ITRI icon
3
Itron
ITRI
$4.75B
$25.1M 4.24%
348,000
-137,950
-28% -$8.72M
BIOX icon
4
Bioceres Crop Solutions
BIOX
$20.6M
$24.8M 4.18%
1,852,703
-89,947
-5% -$1.05M
FSLR icon
5
First Solar
FSLR
$21.8B
$14.7M 2.49%
77,500
-109,500
-59% -$21.7M
VST icon
6
Vistra
VST
$50.1B
$14M 2.37%
533,500
-126,000
-19% -$3.08M
HLIT icon
7
Harmonic Inc
HLIT
$1.2B
$14M 2.36%
863,500
-211,250
-20% -$3.39M
RUN icon
8
Sunrun
RUN
$2.3B
$12.9M 2.19%
725,000
+103,500
+17% +$1.92M
PACB icon
9
Pacific Biosciences
PACB
$432M
$12M 2.04%
906,000
ASPN icon
10
Aspen Aerogels
ASPN
$364M
$11.9M 2.02%
1,511,678
+765,678
+103% +$5.33M
LEGN icon
11
Legend Biotech
LEGN
$3.68B
$11M 1.87%
160,000
-20,000
-11% -$1.31M
ASPN icon
12
CALL
Aspen Aerogels
ASPN
$364M
$10.7M 1.8%
+1,351,000
New +$9.4M
GEN icon
13
CALL
Gen Digital
GEN
$16.6B
$10.2M 1.72%
+550,000
New +$9.62M
PCOR icon
14
Procore
PCOR
$7.37B
$10.2M 1.72%
+156,000
New +$9.18M
EVLV icon
15
Evolv Technologies
EVLV
$1.01B
$9.94M 1.68%
1,656,000
-226,500
-12% -$1.07M
FLEX icon
16
Flex
FLEX
$41.5B
$9.76M 1.65%
468,431
-179,145
-28% -$3.19M
S icon
17
SentinelOne
S
$6.29B
$9.7M 1.64%
642,250
+402,500
+168% +$6.81M
AMZN icon
18
Amazon
AMZN
$2.48T
$9.23M 1.56%
71,000
+61,000
+610% +$6.97M
UTHR icon
19
United Therapeutics
UTHR
$26.1B
$8.83M 1.49%
+40,000
New +$8.86M
FTAI icon
20
FTAI Aviation
FTAI
$21.8B
$8.44M 1.43%
266,500
-41,000
-13% -$1.16M
IRM icon
21
Iron Mountain
IRM
$37.4B
$8.24M 1.39%
145,000
FLR icon
22
Fluor
FLR
$6.89B
$8.24M 1.39%
278,250
+11,250
+4% +$323K
STEM icon
23
Stem
STEM
$47.7M
$8.03M 1.36%
70,150
+3,650
+5% +$362K
MSFT icon
24
Microsoft
MSFT
$2.92T
$7.92M 1.34%
23,250
+1,100
+5% +$345K
DAL icon
25
Delta Air Lines
DAL
$58.8B
$7.61M 1.29%
+160,000
New +$5.9M

Similar funds

Ardsley Advisory Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Ardsley Advisory Partners held 162 positions worth $592M, up 30% from $455M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ardsley Advisory Partners deployed $94.5M of net new capital in Q2 2023, opening 61 new positions and adding to 29 existing holdings. Its largest new stake was Procore: 156,000 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 39% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was First Solar, an estimated $21.7M trimmed.

  • Ardsley Advisory Partners's largest Q2 2023 buy was Procore: 156,000 shares worth $10.2M.
  • Ardsley Advisory Partners added most to SunOpta in Q2 2023, an estimated $10.2M increase.
  • Ardsley Advisory Partners's biggest Q2 2023 reduction was First Solar, cutting an estimated $21.7M.
  • Ardsley Advisory Partners fully exited Walt Disney in Q2 2023, selling an estimated $18.7M.
  • Ardsley Advisory Partners's ten largest holdings make up 42% of its $592M portfolio in Q2 2023.
  • Ardsley Advisory Partners opened 61 new positions and closed 41 in Q2 2023.
  • Ardsley Advisory Partners's portfolio value rose 30% quarter-over-quarter to $592M.

Based on Ardsley Advisory Partners's 13F filing for Q2 2023, filed 14 Aug 2023.